INSMED INC Variable Lease, Cost
INSMED INC (INSM) reported Variable Lease, Cost of $5.30 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-06
- INSMED INC variable lease, cost for the quarter ending 2026-06-30 was $5.30M, a 55.88% increase year-over-year.
- INSMED INC variable lease, cost for the quarter ending 2026-03-31 was $7.60M, a 204.00% increase year-over-year.
- INSMED INC variable lease, cost for the quarter ending 2025-12-31 was $3.56M, a 34.22% decline year-over-year.
- INSMED INC variable lease, cost for the quarter ending 2025-09-30 was $15.30M, a 24.39% increase year-over-year.
- INSMED INC variable lease, cost for fiscal 2025 was $24.76M, a 4.08% decline from fiscal 2024.
- INSMED INC variable lease, cost for fiscal 2024 was $25.82M, a 82.49% increase from fiscal 2023.
- INSMED INC variable lease, cost for fiscal 2023 was $14.15M, a 25.72% increase from fiscal 2022.
- INSMED INC variable lease, cost for fiscal 2022 was $11.25M, a 59.79% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.30M 10-Q · filed 2026-08-06 | $12.90M 10-Q · filed 2026-08-06 | $16.46M derived: sum of 3 quarters · filed 2026-08-06 | $31.76M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $7.60M 10-Q · filed 2026-05-07 | $11.16M derived: sum of 2 quarters · filed 2026-05-07 | $26.46M derived: sum of 3 quarters · filed 2026-05-07 | $29.86M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $3.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $18.86M derived: sum of 2 quarters · filed 2026-02-19 | $22.26M derived: sum of 3 quarters · filed 2026-08-06 | $24.76M 10-K · filed 2026-02-19 |
| 2025-09-30 | $15.30M 10-Q · filed 2025-10-30 | $18.70M derived: sum of 2 quarters · filed 2026-08-06 | $21.20M 10-Q · filed 2025-10-30 | $26.62M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $3.40M 10-Q · filed 2026-08-06 | $5.90M 10-Q · filed 2026-08-06 | $11.32M derived: sum of 3 quarters · filed 2026-08-06 | $23.62M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $2.50M 10-Q · filed 2026-05-07 | $7.92M derived: sum of 2 quarters · filed 2026-05-07 | $20.22M derived: sum of 3 quarters · filed 2026-05-07 | $23.42M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $5.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $17.72M derived: sum of 2 quarters · filed 2026-02-19 | $20.92M derived: sum of 3 quarters · filed 2026-02-19 | $25.82M 10-K · filed 2026-02-19 |
| 2024-09-30 | $12.30M 10-Q · filed 2025-10-30 | $15.50M derived: sum of 2 quarters · filed 2025-10-30 | $20.40M 10-Q · filed 2025-10-30 | $26.45M derived: sum of 4 quarters · filed 2025-10-30 |
| 2024-06-30 | $3.20M 10-Q · filed 2025-08-07 | $8.10M 10-Q · filed 2025-08-07 | $14.15M derived: sum of 3 quarters · filed 2025-08-07 | $18.05M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $4.90M 10-Q · filed 2025-05-08 | $10.95M derived: sum of 2 quarters · filed 2025-05-08 | $14.85M derived: sum of 3 quarters · filed 2025-05-08 | $18.95M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $6.05M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $9.95M derived: sum of 2 quarters · filed 2025-02-20 | $14.05M derived: sum of 3 quarters · filed 2025-02-20 | $14.15M 10-K · filed 2025-02-20 |
| 2023-09-30 | $3.90M 10-Q · filed 2024-10-31 | $8.00M derived: sum of 2 quarters · filed 2024-10-31 | $8.10M 10-Q · filed 2024-10-31 | $14.45M derived: sum of 4 quarters · filed 2024-10-31 |
| 2023-06-30 | $4.10M 10-Q · filed 2024-08-08 | $4.20M 10-Q · filed 2024-08-08 | $10.55M derived: sum of 3 quarters · filed 2024-08-08 | $13.75M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $100.00K 10-Q · filed 2024-05-09 | $6.45M derived: sum of 2 quarters · filed 2024-05-09 | $9.65M derived: sum of 3 quarters · filed 2024-05-09 | $11.15M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $6.35M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $9.55M derived: sum of 2 quarters · filed 2024-02-22 | $11.05M derived: sum of 3 quarters · filed 2024-02-22 | $11.25M 10-K · filed 2024-02-22 |
| 2022-09-30 | $3.20M 10-Q · filed 2023-10-26 | $4.70M derived: sum of 2 quarters · filed 2023-10-26 | $4.90M 10-Q · filed 2023-10-26 | $7.24M derived: sum of 4 quarters · filed 2023-10-26 |
| 2022-06-30 | $1.50M 10-Q · filed 2023-08-03 | $1.60M 10-Q · filed 2023-08-03 | $4.04M derived: sum of 3 quarters · filed 2023-08-03 | $8.24M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $100.00K 10-Q · filed 2023-05-04 | $2.54M derived: sum of 2 quarters · filed 2023-05-04 | $6.74M derived: sum of 3 quarters · filed 2023-05-04 | $6.94M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $2.44M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $6.64M derived: sum of 2 quarters · filed 2023-02-23 | $6.84M derived: sum of 3 quarters · filed 2023-02-23 | $7.04M 10-K · filed 2023-02-23 |
| 2021-09-30 | $4.20M 10-Q · filed 2022-10-27 | $4.40M derived: sum of 2 quarters · filed 2022-10-27 | $4.60M 10-Q · filed 2022-10-27 | $7.45M derived: sum of 4 quarters · filed 2022-10-27 |
| 2021-06-30 | $200.00K 10-Q · filed 2022-08-04 | $300.00K 10-Q · filed 2022-08-04 | $3.25M derived: sum of 3 quarters · filed 2022-08-04 | $9.25M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $200.00K 10-Q · filed 2022-05-05 | $3.05M derived: sum of 2 quarters · filed 2022-05-05 | $9.05M derived: sum of 3 quarters · filed 2022-05-05 | $10.05M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $2.85M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $8.85M derived: sum of 2 quarters · filed 2022-02-17 | $9.85M derived: sum of 3 quarters · filed 2022-02-17 | $9.95M 10-K · filed 2022-02-17 |
| 2020-09-30 | $6.00M 10-Q · filed 2021-10-28 | $7.00M derived: sum of 2 quarters · filed 2021-10-28 | $7.10M 10-Q · filed 2021-10-28 | |
| 2020-06-30 | $1.00M 10-Q · filed 2021-08-05 | $1.10M 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $100.00K 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $92.00K 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |